1,1-dichloroethene decreases expression ISO RGD:1322378 6480464 vinylidene chloride results in decreased expression of CDA mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO RGD:1322378 6480464 ethylene dichloride results in increased expression of CDA mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1322378 6480464 1, 2-Dimethylhydrazine results in decreased expression of CDA mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1322377 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of CDA mRNA, [Progesterone co-treated with Estradiol] affects the expression of CDA mRNA CTD PMID:17404688 , PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1322378 6480464 2 more ... CTD PMID:30294300 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1322378 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322377 6480464 Tetrachlorodibenzodioxin results in increased expression of CDA mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDA mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322378 6480464 Tetrachlorodibenzodioxin results in increased expression of CDA mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322378 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDA mRNA CTD PMID:21354282 , PMID:28922406 2,4-diaminotoluene increases expression ISO RGD:1322378 6480464 2, 4-diaminotoluene results in increased expression of CDA mRNA CTD PMID:20713471 2-hydroxypropanoic acid decreases expression ISO RGD:1322377 6480464 Lactic Acid results in decreased expression of CDA mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of CDA mRNA CTD PMID:27914987 3-methylcholanthrene increases expression ISO RGD:1322378 6480464 Methylcholanthrene results in increased expression of CDA mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide increases expression ISO RGD:1322378 6480464 Fenretinide results in increased expression of CDA mRNA CTD PMID:28973697 4-tert-Octylphenol increases expression ISO RGD:1322378 6480464 4-tert-octylphenol results in increased expression of CDA mRNA, 4-tert-octylphenol results in increased expression of CDA protein CTD PMID:30487447 5'-Deoxy-5-fluorocytidine increases metabolic processing ISO RGD:1322378 6480464 CDA protein results in increased metabolism of 5'-deoxy-5-fluorocytidine CTD PMID:18077151 5-aza-2'-deoxycytidine increases degradation ISO RGD:1322377 6480464 CDA protein results in increased degradation of Decitabine CTD PMID:17616700 5-fluorocytidine increases metabolic processing ISO RGD:1322377 6480464 CDA protein results in increased metabolism of 5-fluorocytidine CTD PMID:21804305 5-fluorocytidine increases metabolic processing ISO RGD:1322378 6480464 CDA protein results in increased metabolism of 5-fluorocytidine CTD PMID:21804305 5-fluorouracil multiple interactions EXP 6480464 [CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil], [CYP2B1 co-treated with CDA] results in increased susceptibility to Fluorouracil CTD PMID:10811482 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CDA mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CDA mRNA CTD PMID:22504374 aflatoxin B1 increases expression ISO RGD:1322377 6480464 Aflatoxin B1 results in increased expression of CDA mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:1322377 6480464 Aflatoxin B1 results in decreased methylation of CDA intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1322377 6480464 Tretinoin results in increased expression of CDA mRNA CTD PMID:33167477 amiodarone increases expression ISO RGD:1322378 6480464 Amiodarone results in increased expression of CDA mRNA CTD PMID:24535564 arsenite(3-) multiple interactions ISO RGD:1322377 6480464 arsenite promotes the reaction [G3BP1 protein binds to CDA mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO RGD:1322378 6480464 Benzo(a)pyrene results in increased expression of CDA mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1322377 6480464 Benzo(a)pyrene results in increased expression of CDA mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1322377 6480464 Benzo(a)pyrene affects the methylation of CDA promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1322377 6480464 Benzo(a)pyrene results in increased methylation of CDA 3' UTR, Benzo(a)pyrene results in increased methylation of CDA exon CTD PMID:27901495 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1322378 6480464 Diethylhexyl Phthalate results in increased expression of CDA mRNA CTD PMID:28085963 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CDA mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1322378 6480464 bisphenol A results in increased expression of CDA mRNA CTD PMID:32156529 bisphenol A affects expression ISO RGD:1322377 6480464 bisphenol A affects the expression of CDA mRNA CTD PMID:30903817 cadmium atom increases expression ISO RGD:1322377 6480464 Cadmium results in increased expression of CDA mRNA CTD PMID:21120746 calciol increases expression ISO RGD:1322377 6480464 Cholecalciferol results in increased expression of CDA mRNA CTD PMID:18537153 calcitriol increases expression ISO RGD:1322377 6480464 Calcitriol results in increased expression of CDA mRNA CTD PMID:16002434 captan increases expression ISO RGD:1322378 6480464 Captan results in increased expression of CDA mRNA CTD PMID:31558096 carbon nanotube increases expression ISO RGD:1322378 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 celastrol increases expression ISO RGD:1322377 6480464 celastrol results in increased expression of CDA mRNA CTD PMID:27374097 chlorambucil decreases response to substance ISO RGD:1322377 6480464 CDA protein results in decreased susceptibility to Chlorambucil CTD PMID:10830723 choline multiple interactions ISO RGD:1322378 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDA mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1322378 6480464 chromium hexavalent ion affects the expression of CDA mRNA CTD PMID:28472532 cisplatin multiple interactions ISO RGD:1322377 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CDA mRNA CTD PMID:27392435 copper(II) sulfate increases expression ISO RGD:1322377 6480464 Copper Sulfate results in increased expression of CDA mRNA CTD PMID:19549813 crizotinib decreases expression ISO RGD:1322377 6480464 crizotinib results in decreased expression of CDA protein CTD PMID:22973962 crizotinib multiple interactions ISO RGD:1322377 6480464 [Crizotinib results in decreased expression of CDA protein] which results in increased susceptibility to Gemcitabine CTD PMID:22973962 cyclosporin A affects expression ISO RGD:1322377 6480464 Cyclosporine affects the expression of CDA mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1322377 6480464 Cyclosporine results in increased expression of CDA mRNA CTD PMID:25562108 dexamethasone increases activity ISO RGD:1322378 6480464 Dexamethasone results in increased activity of CDA protein CTD PMID:6882797 dextran sulfate multiple interactions ISO RGD:1322378 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDA mRNA CTD PMID:29950665 dichloroacetic acid increases expression ISO RGD:1322378 6480464 Dichloroacetic Acid results in increased expression of CDA mRNA CTD PMID:28962523 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CDA mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:1322377 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1322377 6480464 entinostat results in increased expression of CDA mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1322377 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDA mRNA CTD PMID:27188386 epoxiconazole affects expression ISO RGD:1322378 6480464 epoxiconazole affects the expression of CDA mRNA CTD PMID:35436446 fipronil increases expression EXP 6480464 fipronil results in increased expression of CDA mRNA CTD PMID:23962444 folic acid multiple interactions ISO RGD:1322378 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDA mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1322378 6480464 Folic Acid results in decreased expression of CDA mRNA CTD PMID:25629700 folpet increases expression ISO RGD:1322378 6480464 folpet results in increased expression of CDA mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:1322377 6480464 Formaldehyde results in increased expression of CDA mRNA CTD PMID:27664576 furan increases expression EXP 6480464 furan results in increased expression of CDA mRNA CTD PMID:25539665 gemcitabine affects response to substance ISO RGD:1322377 6480464 CDA protein affects the susceptibility to Gemcitabine CTD PMID:18728667 gemcitabine multiple interactions ISO RGD:1322377 6480464 [Crizotinib results in decreased expression of CDA protein] which results in increased susceptibility to Gemcitabine more ... CTD PMID:18728667 , PMID:22973962 genistein decreases expression ISO RGD:1322378 6480464 Genistein results in decreased expression of CDA mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CDA mRNA CTD PMID:33387578 gold atom multiple interactions ISO RGD:1322378 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA CTD PMID:19695318 gold(0) multiple interactions ISO RGD:1322378 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA CTD PMID:19695318 hydrogen peroxide affects expression ISO RGD:1322377 6480464 Hydrogen Peroxide affects the expression of CDA mRNA CTD PMID:20044591 ifosfamide multiple interactions EXP 6480464 [CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil], [CYP2B1 co-treated with CDA] results in increased susceptibility to Ifosfamide CTD PMID:10811482 isotretinoin decreases expression ISO RGD:1322377 6480464 Isotretinoin results in decreased expression of CDA mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:1322378 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDA mRNA CTD PMID:20938992 melphalan decreases response to substance ISO RGD:1322377 6480464 CDA protein results in decreased susceptibility to Melphalan CTD PMID:10830723 methimazole increases expression EXP 6480464 Methimazole results in increased expression of CDA mRNA CTD PMID:22504374 mitomycin C multiple interactions ISO RGD:1322377 6480464 CDA protein affects the susceptibility to [Gemcitabine co-treated with Mitomycin] CTD PMID:18728667 oxaliplatin multiple interactions ISO RGD:1322377 6480464 CDA protein affects the susceptibility to [Gemcitabine co-treated with Oxaliplatin] CTD PMID:18728667 p-tert-Amylphenol increases expression ISO RGD:1322378 6480464 4-tert-octylphenol results in increased expression of CDA mRNA, 4-tert-octylphenol results in increased expression of CDA protein CTD PMID:30487447 paclitaxel affects response to substance ISO RGD:1322377 6480464 CDA protein affects the susceptibility to Paclitaxel CTD PMID:18728667 paracetamol affects expression ISO RGD:1322378 6480464 Acetaminophen affects the expression of CDA mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CDA mRNA CTD PMID:33387578 phenobarbital decreases expression ISO RGD:1322378 6480464 Phenobarbital results in decreased expression of CDA mRNA CTD PMID:19270015 phenylmercury acetate decreases expression ISO RGD:1322377 6480464 Phenylmercuric Acetate results in decreased expression of CDA mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1322377 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDA mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1322378 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CDA mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1322378 6480464 pirinixic acid results in increased expression of CDA mRNA CTD PMID:17426115 more ... progesterone multiple interactions ISO RGD:1322377 6480464 [Progesterone co-treated with Estradiol] affects the expression of CDA mRNA CTD PMID:17404688 protein kinase inhibitor multiple interactions ISO RGD:1322377 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CDA mRNA] CTD PMID:28003376 quercetin increases expression ISO RGD:1322377 6480464 Quercetin results in increased expression of CDA mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1322377 6480464 Lactic Acid results in decreased expression of CDA mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1322377 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1322377 6480464 Silicon Dioxide analog results in increased expression of CDA mRNA, Silicon Dioxide results in increased expression of CDA mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide decreases expression ISO RGD:1322378 6480464 Silicon Dioxide results in decreased expression of CDA mRNA CTD PMID:23221170 silver atom increases expression ISO RGD:1322378 6480464 Silver results in increased expression of CDA mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1322378 6480464 Silver results in increased expression of CDA mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:1322377 6480464 sodium arsenite results in increased expression of CDA mRNA CTD PMID:22714537 succimer multiple interactions ISO RGD:1322378 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDA mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDA mRNA CTD PMID:21641980 , PMID:26378955 sulforaphane increases expression ISO RGD:1322377 6480464 sulforaphane results in increased expression of CDA mRNA CTD PMID:26833863 sulforaphane decreases expression ISO RGD:1322377 6480464 sulforaphane results in decreased expression of CDA mRNA CTD PMID:31838189 tamoxifen decreases expression ISO RGD:1322378 6480464 Tamoxifen results in decreased expression of CDA mRNA CTD PMID:25123088 tamoxifen affects expression ISO RGD:1322378 6480464 Tamoxifen affects the expression of CDA mRNA CTD PMID:20937368 Tegafur affects response to substance ISO RGD:1322377 6480464 CDA gene polymorphism affects the susceptibility to Tegafur CTD PMID:18537153 testosterone decreases expression ISO RGD:1322377 6480464 Testosterone results in decreased expression of CDA mRNA CTD PMID:33359661 tetrachloromethane increases expression ISO RGD:1322378 6480464 Carbon Tetrachloride results in increased expression of CDA mRNA CTD PMID:31919559 titanium dioxide increases expression ISO RGD:1322378 6480464 titanium dioxide results in increased expression of CDA mRNA CTD PMID:27760801 titanium dioxide multiple interactions ISO RGD:1322378 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDA mRNA CTD PMID:29950665 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CDA mRNA CTD PMID:33387578 valproic acid increases expression ISO RGD:1322378 6480464 Valproic Acid results in increased expression of CDA mRNA CTD PMID:24535564 valproic acid increases expression ISO RGD:1322377 6480464 Valproic Acid results in increased expression of CDA mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1322377 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDA mRNA CTD PMID:27188386
